The document discusses corneal cross-linking (CXL) as a method to strengthen the cornea using UV light and riboflavin, detailing its evolution since its inception in 1998. It emphasizes the potential benefits of customized CXL, which targets treatment specifically to weak areas of the keratoconus cone, and presents various studies comparing outcomes of customized versus conventional techniques. Key findings indicate customized CXL may lead to greater corneal flattening and improved visual acuity compared to standard methods.